|
(2S,3R)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid, 98%
|
|
186132-96-7
|
|
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid, 95%
|
|
102849-49-0
|
|
(2S,3R)-3-(Boc-amino)-2-hydroxy-4-phenylbutyric acid, 98.0%(TLC)
|
|
62023-65-8
|
|
Palmitoyl Tripeptide 38
|
|
1447824-23-8
|
|
(5-CHLORO-2-METHOXYPYRIDIN-3-YL)BORONIC ACID
|
|
943153-22-8
|
|
3,6-Dioxa-1,8-Octanedithiol
|
|
14970-87-7
|
|
Remdesivir
|
|
1809249-37-3
|
|
RU-58841
|
|
154992-24-2
|
|
CFI-402257
|
|
1610759-22-2
|
|
3-Bromo-6-chloro-2-methoxypyridine
|
|
1211526-62-3
|
|
3-PHENOXYBENZHYDRAZIDE
|
|
206761-84-4
|
|
KRYPTOFIX(R) 221
|
|
31364-42-8
|
|
HYDROXYFLUTAMIDE
|
|
52806-53-8
|
|
Triheptanoin
|
|
620-67-7
|
|
1-Butyl-3-methylimidazolium tetrafluoroborate
|
|
174501-65-6
|
|
4-METHACRYLOXYETHYL TRIMELLITIC ANHYDRIDE
|
|
70293-55-9
|
|
ETHYL 2,3,4,6-TETRA-O-ACETYL-ALPHA-D-THIOGLUCOPYRANOSIDE
|
|
52645-73-5
|
|
POLYCARBOMETHYLSILANE
|
|
62306-27-8
|
|
DICHLORO-[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLYLIDENE]-(3-CHLOROPYRIDYL)PALLADIUM(II)
|
|
905459-27-0
|
|
Pyrroloquinoline quinone
|
|
72909-34-3
|
|
Lactitol monohidrate
|
|
585-86-4
|
|
lithospermic acid B
|
|
121521-90-2
|
|
ARG-GLY-ASP
|
|
99896-85-2
|
|
1,1'-(isopropylidene)bis[3,5-dibromo-4-(2,3-dibromo-2-methylpropoxy)benzene]
|
|
97416-84-7
|
|
1-Acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate
|
|
3030-06-6
|
|
5-Aza-2'-deoxycytidine
|
|
2353-33-5
|
|
Poly(vinyl ethyl ether)
|
|
25104-37-4
|
|
6-BROMO-2-NAPHTHYL-BETA-D-GLUCOPYRANOSIDE
|
|
15548-61-5
|
|
Ethyl (1S,2R)-2-Aminocyclopentanecarboxylate, ≥95%
|
|
197904-11-3
|
|
Methyl (2R,3R)-2-Methylpiperidine-3-carboxylate, 95%
|
|
1864003-05-3
|
|
(1R,2S)-2-((Tert-butoxycarbonyl)amino)cyclopentanecarboxylic acid, 98%
|
|
130981-12-3
|
|
Ethyl (1S,2S)-2-Aminocyclopentanecarboxylate, ≥95%
|
|
752181-59-2
|
|
Ethyl (1S,2R)-2-(Cbz-amino)cyclopentanecarboxylate, ≥95%
|
|
1140972-32-2
|
|
(1S,2R)-2-(Boc-amino)cyclopentanecarboxylic Acid, ≥97%
|
|
137170-89-9
|
|
Ethyl (1R,2S)-2-Aminocyclopentanecarboxylate, ≥95%
|
|
197916-36-2
|
|
Ethyl (1R,2S)-2-(Boc-amino)cyclopentanecarboxylate, 95%
|
|
1140972-29-7
|
|
(1R,2S)-2-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid, 95%
|
|
352356-38-8
|
|
Ethyl (1S,2R)-2-(Boc-amino)cyclopentanecarboxylate, ≥95%
|
|
1140972-31-1
|
|
(1R,4R)-4-((Tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid, 95%
|
|
298716-03-7
|
|
Ethyl (1R,2S)-2-(Cbz-amino)cyclopentanecarboxylate, ≥95%
|
|
1140972-27-5
|
|
(+/-)-2-Acetylaminobutanoic Acid-d3, BR
|
|
1219397-36-0
|
|
Ethyl (1R,2R)-2-Aminocyclopentanecarboxylate, ≥95%
|
|
1609100-30-2
|
|
BOEHMITE
|
|
1318-23-6
|
|
Entrectinib
|
|
1108743-60-7
|
|
Ensartinib (X-376)
|
|
1365267-27-1
|
|
Larotrectinib sulfate
|
|
1223405-08-0
|
|
Brigatinib
|
|
1197953-54-0
|
|
Crizotinib
|
|
877399-52-5
|
|
Buparlisib Hydrochloride
|
|
1312445-63-8
|
|
BenzaMide (INCB28060)
|
|
1029712-80-8
|
|
Lorlatinib (PF0643922)
|
|
1454846-35-5
|
|
Repotrectinib (TPX-005)
|
|
1802220-02-5
|
|
P-AMINOPHENYL BETA-D-GLUCOPYRANOSIDE
|
|
20818-25-1
|
|
FMOC-L-SER(BETA-D-GLCAC4)-OH
|
|
118358-38-6
|
|
(3R,4S,5R,6R)-3,4,5-TRIS(BENZYLOXY)-TETRAHYDRO-6-METHYLPYRAN-2-ONE
|
|
1461750-25-3
|
|
Betrixaban maleate
|
|
330942-05-7
|
|
Tucatinib
|
|
937263-43-9
|
|
Fluorescein 5(6)-isothiocyanate
|
|
27072-45-3
|
|
Tri-O-acetyl-D-glucal
|
|
2873-29-2
|
|
D-Glucal
|
|
13265-84-4
|
|
β-D-Glucose pentaacetate
|
|
604-69-3
|
|
2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE
|
|
13096-62-3
|
|
Bempedoic acid (ETC-1002)
|
|
738606-46-7
|
|
Ruxolitinib phosphate
|
|
941678-49-5
|
|
Lenvatinib
|
|
417716-92-8
|
|
Olaparib
|
|
763113-22-0
|
|
Cabozantinib S-malate
|
|
1140909-48-3
|
|
(2S,4R)-1-(Tert-butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid, 97%
|
|
364750-80-1
|
|
Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate, ≥95%
|
|
121148-01-4
|
|
(2S,4R)-4-Hydroxypyrrolidine-2-carboxamide Hydrochloride, ≥95%
|
|
32934-42-2
|
|
3,6-dibroMo-1,2-BenzenediaMine
|
|
69272-50-0
|
|
Copper glycinate
|
|
13479-54-4
|
|
SEC-BUTYLLITHIUM
|
|
598-30-1
|
|
Lithium oxide
|
|
12057-24-8
|
|
Methyl 2,3,4-tri-O-benzyl-alpha-D-glucopyranoside
|
|
53008-65-4
|
|
AMINOPROPYL TERMINATED POLYDIMETHYLSILOXANE
|
|
106214-84-0
|
|
2-PHENOXYETHYL METHACRYLATE
|
|
10595-06-9
|
|
(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine N-acetyl-L-leucine salt
|
|
608141-43-1
|
|
(S)-3-Hydroxy-gamma-butyrolactone
|
|
7331-52-4
|
|
4-Chloro-3-methoxyaniline
|
|
13726-14-2
|
|
Poly(ε-caprolactone)
|
|
24980-41-4
|
|
3',4',5'-trifluorobiphenyl-2-aMine
|
|
915416-45-4
|
|
4-(10,15,20-Triphenyl-21H,23H-porphin-5-yl)benzenamine
|
|
67605-64-5
|
|
4,7-dibroMo-5,6-dinitrobenzo[c][1,2,5]thiadiazole
|
|
76186-72-6
|
|
Tributyl-[4-(2-ethyl-hexyl)-thiophen-2-yl]-stannane
|
|
886746-54-9
|
|
2-CyanoethylN,N-diisopropylchlorophosphoramidite
|
|
89992-70-1
|
|
4,4'-Di-tert-butyl-2,2'-bipyridine
|
|
72914-19-3
|
|
2,3,6,7,14,15-Hexabromo-9,10-dihydro-9,10-[1,2]benzenoanthracene
|
|
55805-81-7
|
|
1,2,3,4,5,6-Benzenehexamine-3HCl
|
|
4444-26-2
|
|
1,10-Phenanthroline-5,6-dione,3,8-dibromo
|
|
602331-25-9
|
|
4-Bromo-4'-hydroxybiphenyl
|
|
29558-77-8
|
|
Benzene,1,1'-(1,2-diphenyl-1,2-ethenediyl)bis[4-broMo-
|
|
184239-35-8
|
|
4,4',4'',4'''-(pyrene-1,3,6,8-tetrayl)tetraaniline
|
|
1610471-69-6
|
|
1 10-PHENANTHROLINE-5 6-DIONE 97
|
|
27318-90-7
|
|
1,4-DIHYDROXY-2,5-DIIODOBENZENE
|
|
13064-64-7
|
|
2,5-Cyclohexadiene-1,4-dione, 2,3,5,6-tetraamino-
|
|
1128-13-8
|
|
2-Cyanoethyl N,N,N',N'-tetraisopropylphosphorodiamidite
|
|
102691-36-1
|
|
LOXO-292
|
|
2222755-14-6
|